Physician profile
Julia Agapov
NPI 1861428153
$25,808.49
in general payments reported to CMS, 2019-2025
7 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $114 · 2021: $2,313 · 2022: $1,899 · 2023: $193 · 2024: $238 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,500.00 |
| Food and Beverage | $982.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nova Eye, INC. | $20,500.00 | 2025 | |
| Allergan, INC. | $2,399.93 | 2021-2022 | |
| Abbvie INC. | $2,079.24 | 2022-2025 | Xen Glaucoma Treatment System |
| Alcon Vision LLC | $463.03 | 2021-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Glaukos Corporation | $149.41 | 2025 | Idosetr, Istent Infinite |
| Aerie Pharmaceuticals, INC. | $114.16 | 2020 | |
| New World Medical,INC. | $102.72 | 2025 | Via360, Streamline, Ahmed Glaucoma Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Agapov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.